AsOf

Recorded or changed on this day 2026-11-08

2,051–2,100 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 23,747,000,000 United States dollar
Amgen revenue: 23,747,000,000 United States dollar, claim clm_340FB654E4B9 · ended · superseded by clm_8EF1DBCB836F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 10,927,000,000 United States dollar
Amgen total equity: 10,927,000,000 United States dollar, claim clm_348858F3E721 · ended · superseded by clm_183536BBBD61 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 54,298,000,000 United States dollar
Amgen total assets: 54,298,000,000 United States dollar, claim clm_3519CC2C0B29 · ended · superseded by clm_C67140F0772C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,678,000,000 United States dollar
Amgen quarterly operating income: 2,678,000,000 United States dollar, claim clm_352EE42890C4 · ended · superseded by clm_7E3BD1C19435 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,830,000,000 United States dollar
Amgen quarterly net income: 2,830,000,000 United States dollar, claim clm_3554CF74631E · ended · superseded by clm_ABB59844DF49 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,143,000,000 United States dollar
Amgen quarterly net income: 2,143,000,000 United States dollar, claim clm_35CDE21699AB · ended · superseded by clm_1A5FC1FEF0D4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,900,000,000 United States dollar
Amgen quarterly net income: 1,900,000,000 United States dollar, claim clm_363FD391E3A4 · ended · superseded by clm_1DC1E9754547 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · Chair · Robert A. Bradway
Amgen Chair: Robert A. Bradway, claim clm_3662BB7CA128 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,266,000,000 United States dollar
Amgen quarterly net income: 1,266,000,000 United States dollar, claim clm_376CEF6833C7 · ended · superseded by clm_8CA0968C8B53 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 757,021,648 shares
Amgen shares outstanding: 757,021,648 shares, claim clm_37781152ABE8 · ended · superseded by clm_8A83A0002048 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,266,000,000 United States dollar
Amgen cash and equivalents: 6,266,000,000 United States dollar, claim clm_3796FE9524B2 · ended · superseded by clm_8D9D5DB7A5DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,707,000,000 United States dollar
Amgen total assets: 59,707,000,000 United States dollar, claim clm_37D604168646 · ended · superseded by clm_1DF598E8A627 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 78,150,000,000 United States dollar
Amgen total assets: 78,150,000,000 United States dollar, claim clm_37FDCE0641B8 · ended · superseded by clm_7C10FDC2C635 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,334,000,000 United States dollar
Amgen total equity: 9,334,000,000 United States dollar, claim clm_38D0C83AFC61 · ended · superseded by clm_3DEAF95EF6B0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 15,620,000,000 United States dollar
Amgen total equity: 15,620,000,000 United States dollar, claim clm_3940E74F06F0 · ended · superseded by clm_8A7A5177FE47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 71,869,000,000 United States dollar
Amgen total assets: 71,869,000,000 United States dollar, claim clm_397DCD0B0485 · ended · superseded by clm_5116B3B21711 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 52,610,000,000 United States dollar
Amgen total assets: 52,610,000,000 United States dollar, claim clm_39B4E0673406 · ended · superseded by clm_76443A277A6C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,423,000,000 United States dollar
Amgen quarterly operating income: 1,423,000,000 United States dollar, claim clm_39DD16EEE4D1 · ended · superseded by clm_84DD01B3B35F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,323,000,000 United States dollar
Amgen quarterly operating income: 2,323,000,000 United States dollar, claim clm_3A298D9EC5BB · ended · superseded by clm_ADA46DB14C4E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,464,000,000 United States dollar
Amgen quarterly revenue: 5,464,000,000 United States dollar, claim clm_3B1946434040 · ended · superseded by clm_8C784DFC08A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,773,000,000 United States dollar
Amgen quarterly revenue: 5,773,000,000 United States dollar, claim clm_3BAD99E25427 · ended · superseded by clm_756E88917872 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 537,204,943 shares
Amgen shares outstanding: 537,204,943 shares, claim clm_3BD301427B1F · ended · superseded by clm_0715D8B97E5E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 7,428,000,000 United States dollar
Amgen total equity: 7,428,000,000 United States dollar, claim clm_3C68D4BBC3A5 · ended · superseded by clm_25EEFB9574DF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 7,687,000,000 United States dollar
Amgen cash and equivalents: 7,687,000,000 United States dollar, claim clm_3D6D73A86504 · ended · superseded by clm_43AFE12FE2B4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 18,676,000,000 United States dollar
Amgen revenue: 18,676,000,000 United States dollar, claim clm_3D7A43128430 · ended · superseded by clm_4F9F8554DED3 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · revenue · 36,751,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 6,781,000,000 United States dollar
Amgen total equity: 6,781,000,000 United States dollar, claim clm_3DDAC5296A48 · ended · superseded by clm_C48050D45C2E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 8,247,000,000 United States dollar
Amgen total equity: 8,247,000,000 United States dollar, claim clm_3DEAF95EF6B0 · ended · superseded by clm_6DC2B1698886 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 71,164,000,000 United States dollar
Amgen total assets: 71,164,000,000 United States dollar, claim clm_3E0AC172DD20 · ended · superseded by clm_E8B932265B26 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 65,121,000,000 United States dollar
Amgen total assets: 65,121,000,000 United States dollar, claim clm_3E5FFAF79DFE · ended · superseded by clm_F5CDB4E2EE9B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 577,566,383 shares
Amgen shares outstanding: 577,566,383 shares, claim clm_3ED771217180 · ended · superseded by clm_45F0A6B25113 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 18,874,000,000 United States dollar
Amgen total equity: 18,874,000,000 United States dollar, claim clm_3F3775EC0C14 · ended · superseded by clm_5B76104742F7 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · ticker · AMGN
Amgen ticker: AMGN, claim clm_3FB6D299561D · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 9,973,000,000 United States dollar
Amgen operating income: 9,973,000,000 United States dollar, claim clm_3FE1CD809E20 · ended · superseded by clm_1E3D48FD1C81 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · listed on · Nasdaq
Amgen listed on: Nasdaq, claim clm_4091015E92FD · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 24,071,000,000 United States dollar
Amgen total equity: 24,071,000,000 United States dollar, claim clm_40DAD67567CD · ended · superseded by clm_ED303315F19F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,825,000,000 United States dollar
Amgen quarterly net income: 1,825,000,000 United States dollar, claim clm_414F61974288 · ended · superseded by clm_99BF980BB9EA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 7,842,000,000 United States dollar
Amgen net income: 7,842,000,000 United States dollar, claim clm_43A49B7648F8 · ended · superseded by clm_673D61CD1F43 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,145,000,000 United States dollar
Amgen cash and equivalents: 9,145,000,000 United States dollar, claim clm_43AFE12FE2B4 · ended · superseded by clm_FB8BB664393E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 61,165,000,000 United States dollar
Amgen total assets: 61,165,000,000 United States dollar, claim clm_43D551B4FBB5 · ended · superseded by clm_4956EE655EA9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 7,447,000,000 United States dollar
Amgen quarterly revenue: 7,447,000,000 United States dollar, claim clm_458A0C01DCF8 · ended · superseded by clm_CE8800B79AA0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,589,000,000 United States dollar
Amgen quarterly operating income: 1,589,000,000 United States dollar, claim clm_45C687484B85 · ended · superseded by clm_39DD16EEE4D1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 574,553,986 shares
Amgen shares outstanding: 574,553,986 shares, claim clm_45F0A6B25113 · ended · superseded by clm_096FA3E02484 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 1,283,000,000 United States dollar
Amgen cash and equivalents: 1,283,000,000 United States dollar, claim clm_462973430FCC · ended · superseded by clm_58CEE3D787CB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 5,506,000,000 United States dollar
Amgen operating income: 5,506,000,000 United States dollar, claim clm_46A559E6C041 · ended · superseded by clm_2282EE661302 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,373,000,000 United States dollar
Amgen total assets: 59,373,000,000 United States dollar, claim clm_47FB0FC871FE · ended · superseded by clm_5C58544C5DCC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,105,000,000 United States dollar
Amgen quarterly revenue: 6,105,000,000 United States dollar, claim clm_481E925C620E · ended · superseded by clm_92E3CC76739F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 4,052,000,000 United States dollar
Amgen net income: 4,052,000,000 United States dollar, claim clm_4826D0123EC0 · ended · superseded by clm_78DDCE0217FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,196,000,000 United States dollar
Amgen total assets: 59,196,000,000 United States dollar, claim clm_4956EE655EA9 · ended · superseded by clm_D091B9D69D1A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 6,207,000,000 United States dollar
Amgen total equity: 6,207,000,000 United States dollar, claim clm_4988A9F733D5 · ended · superseded by clm_3C68D4BBC3A5 · 1 source (1 primary) · conf 0.95

What the statuses mean